CClinicalTrials.gg
Status unknownNCT05394974JOCONDEUpdated Jun 13, 2022

Joint Consultation Between a Neurologist and a Clinical Psychologist

An observational study in Neurodegenerative Disorders, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-06-13.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

Joint consultations appeared a few years ago in routine medical practice, but they are still not widely used and rarely evaluated.

The primary purpose of the study is to evaluate the impact for the patient of the presence of a clinical psychologist during the joint consultation.

The secondary purpose is to evaluate the impact for the patient and for the neurologist of the presence of a clinical psychologist during the joint consultation

02

Conditions studied

  • Neurodegenerative Disorders

Keywords

  • Joint neurologist
  • psychologist consultation
  • neurodegenerative and/or neurogenetic disease
03

In context

Neurodegenerative Diseases

370 studies on the registry are indexed under Neurodegenerative Diseases; 145 are open to participants now.

This study's planned enrollment of 200 is above the median of 175 across 154 observational studies indexed under Neurodegenerative Diseases.

Browse Neurodegenerative Diseases studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patient with a neurodegenerative and/or neurogenetic disease

Inclusion criteria

  • patient with a neurodegenerative and/or neurogenetic disease
  • adult patient

Exclusion criteria

Exclusion Criteria:

  • dementia
  • age \<18 years
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Patient satisfaction after the consultation assessed by 3 questions on a Likert scale

    5-point Likert scale from which to select a response : 1. Very satisfied. 2. Moderately satisfied. 3. Neither satisfied nor dissatisfied. 4. Moderately dissatisfied. 5. Very dissatisfied.

    Time frame: After consultation et 1 to 3 months later

07

Study locations

1 of 1 sites recruiting
  • Service de Neurologie - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • Mathieu ANHEIM, MD, PhD · Contact · mathieu.anheim@chru-strasbourg.fr · +33388128535
    • Mathieu ANHEIM, MD, PhD · Principal investigator
    • Olivier PUTOIS, MD, PhD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05394974
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
May 27, 2022
Start date
Jun 1, 2021
Primary completion
Jun 1, 2023 (estimated)
Completion
Jun 1, 2023 (estimated)
Last update
Jun 13, 2022

Study contacts

Mathieu ANHEIM, MD, PhD
Contact
mathieu.anheim@chru-strasbourg.fr
+33 3 88 12 85 35
Mathieu ANHEIM, MD, PhD
principal investigator · Service de Neurologie - CHU de Strasbourg - France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion